Hi guys, do you have an access to any of these articles?
Cheadle EJ, Sheard V, Rothwell DG, Bridgeman JS, Ashton G, Hanson V, Mansoor AW, Hawkins RE, Gilham DE (2014). Differential Role of Th1 and Th2 Cytokines in Autotoxicity Driven by CD19-Specific Second-Generation Chimeric Antigen Receptor T Cells in a Mouse Model. J Immunol. 2014 Apr 15;192(8):3654-65. doi: 10.4049/jimmunol.1302148. Epub 2014 Mar 12.
Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne A, Caldas C, Clarke RB, De Jong S, Jonkers J, Mælandsmo GM, Roman‐Roman S, Seoane J, Trusolino L, Villanueva A (2014) Patient Derived Xenograft Models: An Emerging Platform For Translational Cancer Research, Cancer Discovery, 4(9):998-1013.
Singh JK, Farnie G, Bundred NJ, Simões BM, Shergill A, Landberg G, Howell SJ and Clarke RB (2013) Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-dependent and -independent Mechanisms. Clinical Cancer Research, 19 (3); 643-656.
Thank you
